Vivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep ...

“Oral appliance success is traditionally evaluated with the AHI metrics. My experience with the ProSomnus ® EVO ® precision oral appliance is that it exceeds the American Academy of ...

“My experience with ProSomnus began in 2019 and since that time, I have come to appreciate the benefit to my patients in delivering precision oral appliances such as these.

“Oral appliance success is traditionally evaluated with the AHI metrics. My experience with the ProSomnus ® EVO ® precision oral appliance is that it exceeds the American Academy of Sleep Medicine ...

“the updated data and analysis from flosat is validation that precision oral appliance therapy with prosomnus devices is an effective front-line treatment for moderate to severe osa,” said len ...

Precision oral appliance therapy effective among 90% of moderate and 85% of severe OSA patients In an Intent-to-Treat analysis, precision OAT demonstrated twice the mean disease alleviation as ...

News provided by ProSomnus Sleep Technologies, Inc. Aug 23, 2023, 8:00 AM ET Precision oral appliance therapy effective among 90% of moderate and 85% of severe OSA patients In an Intent-to-Treat ...

Precision oral appliance therapy was preferred by patients, with 98% continuing therapy at three months versus 22% discontinuing CPAP therapy over the same period of time In an intention to treat ...

The company’s medical device mindset and data-driven approach set it apart from traditional oral appliances, positioning it as a potential game-changer in the market. ProSomnus has generated data ...

ProSomnus is the first manufacturer of mass-customized Precision Oral Appliance Therapy (OAT) devices to treat OSA, which affects over 74 million people in North America and is associated with ...